Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials

Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain

(2016) E. Niclas Jonsson et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Editorial: Pain Relief in Osteoarthritis: The Potential for a Perfect Storm

(2016) Andrew J. Teichtahl et al.   Arthritis & Rheumatology

When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program

(2016) Marc C. Hochberg et al.   Arthritis & Rheumatology

A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee

(2015) T.J. Schnitzer et al.   OSTEOARTHRITIS AND CARTILAGE

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain

(2014) Thomas J Schnitzer et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen

(2014) E. F. Ekman et al.   JOURNAL OF RHEUMATOLOGY

Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatment

(2014) Mark T. Brown et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

OARSI guidelines for the non-surgical management of knee osteoarthritis

(2014) T.E. McAlindon et al.   OSTEOARTHRITIS AND CARTILAGE

Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain

(2014) Joseph S. Gimbel et al.   PAIN

Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial

(2013) Andra Rodica Balanescu et al.   ANNALS OF THE RHEUMATIC DISEASES

Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

(2013) Mark T. Brown et al.   ARTHRITIS AND RHEUMATISM

A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee

(2013) Egilius L.H. Spierings et al.   PAIN

Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

(2012) Mark T. Brown et al.   JOURNAL OF PAIN

Proof of Concept Trial of Tanezumab for the Treatment of Symptoms Associated With Interstitial Cystitis

(2011) R.J. Evans et al.   JOURNAL OF UROLOGY

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study

(2011) H. Nagashima et al.   OSTEOARTHRITIS AND CARTILAGE

Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain

(2011) T.J. Schnitzer et al.   OSTEOARTHRITIS AND CARTILAGE

Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee

(2010) Nancy E. Lane et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis

(2010) D. A. Walsh et al.   RHEUMATOLOGY

Targeting Nerve Growth Factor in Pain

(2008) Judy J Watson et al.   BIODRUGS

Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors

(2008) Yasmina Noubia Abdiche et al.   PROTEIN SCIENCE